Targeting EGFR signalling pathway in triple negative breast cancer
<p>Epidermal growth factor receptor (EGFR) is frequently overexpressed in the majority of triple negative breast cancer patients (TNBC). However, the molecular determinants behind their limited response to EGFR-targeted therapies are poorly understood. Here, both the acute and chronic response...
Egile nagusia: | Albukhari, A |
---|---|
Beste egile batzuk: | Ahmed, A |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
2014
|
Gaiak: |
Antzeko izenburuak
-
Targeting EGFR signalling pathway in triple negative breast cancer
nork: Albukhari, A
Argitaratua: (2014) -
Novel signalling pathways regulating epithelial-mesenchymal transition in bone metastatic prostate cancer
nork: Rao, SR
Argitaratua: (2014) -
Tumour-stroma interaction in pancreatic cancer
nork: Lunardi, S
Argitaratua: (2013) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
nork: Potter, M
Argitaratua: (2014) -
The role of DLL4-NOTCH signalling in endothelial cell metabolism
nork: Harjes, U
Argitaratua: (2014)